Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L1LJ
|
||||
Former ID |
DIB003273
|
||||
Drug Name |
Bervastatin
|
||||
Synonyms |
LS-2904
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Discontinued in Phase 2 | [1] | ||
Company |
Merck Sante SA
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C28H31FO5
|
||||
Canonical SMILES |
C1(=C(c2c(OC31CCCC3)cccc2)c1ccc(cc1)F)/C=C/[C@@H](C[C@@<br />H](CC(=O)OCC)O)O
|
||||
CAS Number |
CAS 132017-01-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Target Info | Inhibitor | [2] | |
BioCyc Pathway | Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | ||||
Superpathway of cholesterol biosynthesis | |||||
Mevalonate pathway | |||||
KEGG Pathway | Terpenoid backbone biosynthesis | ||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
AMPK signaling pathway | |||||
Bile secretion | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
TSH Signaling Pathway | |||||
PANTHER Pathway | Cholesterol biosynthesis | ||||
PathWhiz Pathway | Steroid Biosynthesis | ||||
WikiPathways | Statin Pathway | ||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Activation of Gene Expression by SREBP (SREBF) | |||||
SREBF and miR33 in cholesterol and lipid homeostasis | |||||
Integrated Breast Cancer Pathway | |||||
SREBP signalling | |||||
Cholesterol Biosynthesis | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002290) | ||||
REF 2 | Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol. 2003 Jan;26(1):18-24. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.